XML 45 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of offering activity

​

​

​

​

​

​

​

​

​

Number of

​

Total

​

​

Shares Purchased

​

Proceeds

Offering Period

​

(in thousands)

November 1, 2018 - April 30, 2019

​

132,177

​

$

2,147

May 1, 2019 - October 31, 2019

​

136,084

​

​

2,176

November 1, 2019 - April 30, 2020

​

97,247

​

​

3,061

May 1, 2020 - October 31, 2020

​

136,288

​

​

4,052

Summary of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Outstanding Options

 

​

    

​

    

​

    

​

    

Weighted-

    

​

 

​

​

​

​

​

​

Weighted-

​

Average

​

​

 

​

​

Shares

​

​

​

Average

​

Remaining

​

Aggregate

 

​

​

Available for

​

Number of

​

Exercise

​

Contractual

​

Intrinsic

 

​

​

Grant

​

Shares

​

Price

​

Life

​

Value

 

(in thousands, except for contractual life and exercise price)

​

​

​

​

​

​

​

​

(in years)

​

​

 

Balance at December 31, 2019

 

6,416

 

8,497

​

$

10.39

 

6.88

​

$

197,955

​

Additional shares authorized

 

3,120

​

—

​

$

—

​

​

​

​

​

​

Options granted

 

(457)

 

457

​

$

27.67

​

​

​

​

​

​

Options exercised

 

—

 

(2,092)

​

$

11.24

​

​

​

​

​

​

Options forfeited/cancelled

 

155

 

(155)

​

$

15.39

​

​

​

​

​

​

RSUs granted (1)

​

(6,204)

​

​

​

​

​

​

​

​

​

​

​

RSUs forfeited/cancelled

​

436

​

​

​

​

​

​

​

​

​

​

​

Balance at December 31, 2020

 

3,466

 

6,707

​

$

11.19

 

6.04

​

$

592,468

​

Exercisable at December 31, 2020

​

​

 

5,080

​

$

9.04

 

5.40

​

$

459,683

​

Vested and expected to vest at December 31, 2020

​

​

 

6,609

​

$

11.09

 

6.01

​

$

584,396

​

Schedule of performance-based awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Period Granted

​

Options Granted

​

RSUs Granted

​

Options Vested

​

RSUs Vested

​

Milestone

​

Valuation Method

(in thousands)

Q1 2019

​

200

​

300

​

138

​

219

​

(1)

​

Monte-Carlo Simulation

Q2 2019

​

—

​

188

​

—

​

—

​

(2)

​

Fair Market Value

Q3 2019

​

—

​

50

​

—

​

25

​

(1)

​

Monte-Carlo Simulation

Q1 2020

​

150

​

300

​

75

​

150

​

(1)

​

Monte-Carlo Simulation

Q1 2020

​

—

​

436

​

—

​

4

​

(3)

​

Fair Market Value

Q1 2020

​

129

​

—

​

—

​

—

​

(3)

​

Black-Scholes-Merton

Q2 2020

​

—

​

21

​

—

​

—

​

(3)

​

Fair Market Value

Q3 2020

​

10

​

—

​

10

​

—

​

(4)

​

Black-Scholes-Merton

Q3 2020

​

—

​

27

​

—

​

5

​

(3)

​

Fair Market Value

Q4 2020

​

—

​

32

​

—

​

—

​

(1)

​

Monte-Carlo Simulation

Q4 2020

​

—

​

22

​

—

​

—

​

(5)

​

Fair Market Value

​

(1)The awards vest based on the achievement of certain values of the Company’s common stock at multiple thresholds within certain periods and are contingent upon the completion of requisite service through the date of such vesting.
(2)The vesting of the awards will be triggered after the end of the achievement milestone, as measured by the Company.
(3)The awards vest based on achievement of certain revenue targets and are contingent upon the completion of requisite service through the date of such vesting.
(4)The awards vest based on achievement of a reimbursement target.
(5)The awards will vest based on achievement of certain revenue and recruiting targets.
Restricted stock units

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

Number of

​

Grant Date

​

​

Shares

​

Fair Value

​

​

(in thousands)

​

​

​

Balance at December 31, 2019

​

2,404

​

$

19.86

Granted

​

3,102

​

$

39.94

Vested

​

(1,100)

​

$

19.69

Canceled/Forfeited

​

(218)

​

$

24.70

Balance at December 31, 2020

 

4,188

​

$

34.02

​

​

​

​

​

​

Summary of stock-based compensation expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 

 

​

​

2020

​

2019

​

2018

 

​

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

 

​

 

(in thousands)

​

Cost of revenues

​

$

1,691

​

$

—

​

$

1,691

​

$

905

​

$

32

​

$

937

​

$

564

​

$

5

​

$

569

​

Research and development

​

 

10,777

​

 

647

​

 

11,424

​

 

5,354

​

 

—

​

 

5,354

​

​

4,043

​

 

—

​

 

4,043

​

Selling, general and administrative

​

 

36,747

​

 

309

​

 

37,056

​

 

21,730

​

 

603

​

 

22,333

​

​

9,474

​

 

112

​

 

9,586

​

Total

​

$

49,215

​

$

956

​

$

50,171

​

$

27,989

​

$

635

​

$

28,624

​

$

14,081

​

$

117

​

$

14,198

​

Performance-based awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31,

December 31,

​

2020

2019

Risk-free interest rate

​

0.54

%

—

1.64

%

​

1.63

%

—

2.61

%

Expected dividend yield

​

​

​

​

—

​

​

​

​

​

—

​

Expected volatility

​

55

%

—

65

%

​

​

​

​

50

%

Expected term (years)

​

5.25

​

—

7.25

​

​

​

​

​

7.25

​

Employee stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended December 31, 

​

   

2020

    

    

2019

    

    

2018

​

Expected term (years)

 

5.22

​

—

10.00

​

​

5.23

​

—

10.00

​

​

5.24

​

—

5.62

​

Expected volatility

 

49.94

%  

—

61.96

%

 

42.53

%  

—

45.84

%

​

40.28

%

—

42.53

%

Expected dividend rate

 

​

​

​

0

%

 

​

​

​

0

%

​

​

​

​

0

%

Risk-free interest rate

 

0.31

%  

—

1.70

%

 

1.60

%  

—

2.60

%

​

2.37

%

—

3.06

%